Bioconsortia
Americas
Davis
,
United States
Scaleup
FOUNDED
2014
HEADCOUNT
21-100
FUNDING
Series D+
Keywords:
bacteria, directed_evolution, gene_editing, nitrogen_fixation, crop_protection, biostimulants, microbiome, omics
BUSINESS
Agricultural microbial products company based in Davis, California. Founded 2014. Uses proprietary Advanced Microbial Selection (AMS) platform; a directed evolution approach that iteratively selects plant microbiomes for desired crop traits, then isolates the responsible microbes. Focuses on Gram-positive spore-forming bacteria for robust shelf life (2+ years) and seed treatment compatibility. Pipeline includes nitrogen fixation (Always-N), bionematicides, biofungicides, and biostimulants. Also uses gene editing (GenExpress, GenePro platforms) for microbial trait enhancement. Partnership with Mosaic Company for commercialization. Field trials across US, Brazil, New Zealand, and Europe
BIOTECH INVOLVEMENT
Core; proprietary microbiome-directed selection platform (AMS) combined with microbial gene editing tools for non-GMO trait enhancement. Differentiates from competitors (Pivot Bio, Azotic) by focusing on Gram-positive spore-formers rather than Gram-negative organisms, trading discovery complexity for superior product stability and formulation flexibility. R&D-focused business model, licensing products to major ag partners for commercialization
TECHNOLOGY PLATFORM
Advanced Microbial Selection (AMS); directed microbiome evolution; genomics
PRIMARY PRODUCTS
Nitrogen-fixing microbial seed treatments; biostimulants; biopesticides